CG Oncology CGON Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$186.75M-76.9% | -$161M-82.9% | -$151.48M-108% | -$128.08M-99.6% | -$105.56M-85.6% | ||
| $2.26M+4,250% | $1.45M+4,416% | $596K+1,556% | $201K+905% | $52K+206% | ||
| $28M+86.2% | $26.68M+134% | $24.48M+240% | $19.8M+301% | $15.04M+425% | ||
| -$160.01M-95.2% | -$132.35M-68.1% | -$116.79M-60.7% | -$93.82M-35.9% | -$81.98M-28.7% | ||
| $422K+76.6% | $134K-43.0% | $336K— | $239K— | $239K— | ||
| —— | —— | —— | —— | —— | ||
| $546.43M+142% | $153.89M-75.5% | $278.23M-31.3% | $226.03M-55.6% | $226.07M-54.2% | ||
| —— | —— | —— | -$10.53M— | —— | ||
| -$160.43M-95.1% | -$132.48M-67.8% | -$117.13M— | -$94.06M— | -$82.22M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does CG Oncology's cash flow data come from?
- Every line is extracted from CG Oncology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.